Market Research Future Reports, Oct. 2025 (Press Release) – The Decentralized Clinical Trials Market Global Outlook

Decentralized Clinical Trials Market examines study design structures, including interventional, observational, and registry trials. It highlights enabling technologies such as telemedicine, wearable devices, and mobile health applications. Therapeutic areas evaluated include oncology, cardiology, neurology, and infectious diseases, while participant engagement strategies include digital surveys, patient-centric approaches, and remote monitoring. The forecast assesses growth across major global regions through 2035.

Decentralized Clinical Trials Market: Transforming Global Clinical Research Through Technology and Patient-Centric Models

The Decentralized Clinical Trials Market is rapidly evolving as pharmaceutical companies, CROs, and healthcare innovators shift toward flexible, remote-enabled clinical study models. The global market value of USD 5.98 Billion in 2023 is expected to reach USD 6.61 Billion in 2024 and further surge to USD 20 Billion by 2035. With a strong CAGR of 10.58% during the forecast period from 2025 to 2035, increasing digitalization and the need for efficient patient recruitment are driving exponential growth in the Decentralized Clinical Trials Market. Organizations across the research ecosystem are actively integrating telemedicine, wearables, and remote monitoring technologies to streamline patient participation and accelerate drug development.